Previous close | 0.1500 |
Open | 0.1500 |
Bid | 0.0000 |
Ask | 0.1500 |
Strike | 0.50 |
Expiry date | 2024-06-21 |
Day's range | 0.1500 - 0.1500 |
Contract range | N/A |
Volume | |
Open interest | 28 |
Boston, June 13, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced that co-founder and visionary healthcare technology leader Roy Schoenberg, M.D., M.P.H., is transitioning from his role as president and co-CEO to become Executive Vice Chairman of Amwell’s Board of Directors. Ido Schoenberg, M.D., will assume the role of sole Chief Executive Officer of Amwell. Since co-founding Amwell in 2006, Roy Schoenberg has been a driving force behind the nation’s embr
Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibilityBoston, May 16, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announced its Co-CEO and President, Roy Schoenberg, M.D., M.P.H., will speak at the Disability & Telehealth Conference at 12:15 PST on Saturday, May 18. The virtual conference explores barriers to telehealth enhancement for those with disabilities an
Telehealth 1.0 is dead, according to one expert. And a new survey says the technology isn't going anywhere.